Abstract
Objective
The current pilot study analyzed feasibility, risk and effectiveness of 1) microsurgery plus stereotactic iodine-125 (125I) brachytherapy (SBT) for large (diameter > 4 cm), circumscribed, and complex located WHO grade II glioma and 2) SBT alone for small (diameter < 4 cm), and complex located recurrences.
Methods
Lowactivity temporary 125I seeds were used. The applied reference dose was 54 Gy and the dose rate was low (median, 10 cGy/h). Time to progression and time to additional external beam radiation (EBR) and/or chemotherapy were estimated with the Kaplan-Meier method. Any adverse sequel potentially attributable to treatment was classified as morbidity. Treatment effects of SBT were estimated according to the modified MacDonald criteria.
Results
Thirtyone patients (de novo group: n = 18, recurrence group: n = 13) were included. The median tumor volume before surgery was 66 ml. A planned partial tumor resection achieved eligibility for SBT in all patients. Transient morbidity of microsurgery and SBT was 27.8 % and 6.4 %, respectively. There was no permanent morbidity. Radiogenic complications did not occur. Complete response, partial response, and stable disease were seen in 8, 9, and 14 patients, respectively. Ten patients exhibited tumor progression (overall 5-year progression- free survival > 60 %). The 5-year probability to receive chemotherapy and/or EBR was 18 %.
Conclusion
A planned partial tumor resection of large and complex located WHO grade II glioma is safe. SBT of small and complex located residual of recurrent tumors is safe and minimally invasive. Combined treatment may provide the possibility to withhold EBR and/or chemotherapy for a considerable number of patients and deserves further prospective evaluation.
Similar content being viewed by others
References
Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG (1999) Pretreatment factors predict overall survival for patients with lowgrade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923–929
Berger MS, Kincaid J, Ojemann GA, Lettich E (1989) Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumours. Neurosurgery 25:786–792
Berger MS, Ojemann GA, Lettich E (1990) Neurophysiological monitoring during astrocytoma surgery. Neurosurg Clin N Am 1:65–80
Brell M, Conesa G, Acebes JJ (2003) Intraoperative cortical mapping in the surgical resection of low-grade glioma located in eloquent areas. Neurochirugia (Astur) 14:491–503
Duffau H, Capelle L, Lopes M, Bitar A, Sichez JP, Van Effenterre R (2002) Medically intractable epilepsy from insular low-grade glioma: improvement after an extended lesionectomy. Acta Neurochir (Wien) 144:563–572
Duffau H, Capelle L, Lopes M, Faillot T, Sichez JP, Fohanno D (2000) The insular lobe: physiopathological and surgical considerations. Neurosurgery 47:801–810
Frappaz D, Chinot O, Bataillard A, Ben Hassel M, Capelle L, Chanalet S, Chatel M, Figarella-Branger D, Guegan Y, Guyotat J, Hoang-Xuan K, Jouanneau E, Keime-Guibert F, Laforet C, Linassier C, Loiseau H, Maire JP, Menei P, Rousmans S, Sanson M, Sunyach MP (2003) Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002). Br J Cancer 89 (Suppl 1):S73–S83
Haglund MM, Berger MS, Shamseldin M, Lettich E, Ojemann GA (1994) Cortical localization of temporal lobe language sites in patients with glioma. Neurosurgery 34:567–576
Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle- Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K (2007) Temozolomide for low-grade glioma: predictive impact of 1p/19q loss on response and outcome. Neurology 68:1831–1836
Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M (2002) Randomized trial on the efficacy of radiotherapy for cerebral lowgrade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316–324
Keles GE, Lundin DA, Lamborn KR, Chang EF, Ojemann G, Berger MS (2004) Intraoperative subcortical stimulation mapping for hemispherical perirolandic glioma located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg 100:369–375
Kreth FW, Faist M, Grau S, Ostertag CB (2006) Interstitial 125I radiosurgery of supratentorial de novo WHO grade II astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer 106:1372–1381
Kreth FW, Faist M, Rossner R, Birg W, Volk B, Ostertag CB (1997) The risk of interstitial radiotherapy of low-grade glioma. Radiother Oncol 43:253–260
Kreth FW, Faist M, Rossner R, Volk B, Ostertag CB (1997) Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors. Cancer 79:370–379
Kreth FW, Faist M, Warnke PC, Rossner R, Volk B, Ostertag CB (1995) Interstitial radiosurgery of low-grade glioma. J Neurosurg 82:418–429
Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ (2001) The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours – a prospective study. Acta Neurochir (Wien) 143:539–545
Lang FF, Olansen NE, DeMonte F, Gokaslan ZL, Holland EC, Kalhorn C, Sawaya R (2001) Surgical resection of intrinsic insular tumours: complication avoidance. J Neurosurg 95:638–650
McDermott MW, Sneed PK, Gutin PH (1998) Interstitial brachytherapy for malignant brain tumours. Semin Surg Oncol 14:79–87
Mehrkens JH, Kreth FW, Muacevic A, Ostertag CB (2004) Long term course of WHO grade II astrocytomas of the Insula of Reil after I-125 interstitial irradiation. J Neurol 251:1455–1464
Ojemann JG, Miller JW, Silbergeld DL (1996) Preserved function in brain invaded by tumour. Neurosurgery 39:253–258
Peraud A, Goetz C, Siefert A, Tonn JC, Kreth FW (2007) Interstitial iodine- 125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located lowgrade glioma: a pilot study. Childs Nerv Syst 23:39–46
Peraud A, Ilmberger J, Reulen HJ (2004) Surgical resection of glioma WHO grade II and III located in the opercular region. Acta Neurochir (Wien) 146:9–17
Peraud A, Meschede M, Eisner W, Ilmberger J, Reulen HJ (2002) Surgical resection of grade II astrocytomas in the superior frontal gyrus. Neurosurgery 50:966–975
Schatz CR, Kreth FW, Faist M, Warnke PC, Volk B, Ostertag CB (1994) Interstitial 125-iodine radiosurgery of lowgrade glioma of the insula of Reil. Acta Neurochir (Wien) 130:80–89
Skirboll SS, Ojemann GA, Berger MS, Lettich E, Winn HR (1996) Functional cortex and subcortical white matter located within glioma. Neurosurgery 38:678–684
Vanaclocha V, Saiz-Sapena N, Garcia- Casasola C (1997) Surgical treatment of insular glioma. Acta Neurochir (Wien ) 139:1126–1134
Author information
Authors and Affiliations
Corresponding author
Additional information
O. Schnell and K. Schöller contributed equally to this study.
Rights and permissions
About this article
Cite this article
Schnell, O., Schöller, K., Ruge, M. et al. Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma – Feasibility and outcome of a combined local treatment concept. J Neurol 255, 1495–1502 (2008). https://doi.org/10.1007/s00415-008-0948-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0948-x